Notably, CD2 expression on CAR-T cells gradually decreased after repeated stimulation by tumor cells, whereas CD19-BBζ + CD2 CAR-T cells maintained significantly increased levels of CD2 expression (Fig. 3G). Here, CD19 is linked to neoplasm.